ATE120753T1 - Bisphosphonsäurederivate als antiarthritische mittel. - Google Patents
Bisphosphonsäurederivate als antiarthritische mittel.Info
- Publication number
- ATE120753T1 ATE120753T1 AT91916549T AT91916549T ATE120753T1 AT E120753 T1 ATE120753 T1 AT E120753T1 AT 91916549 T AT91916549 T AT 91916549T AT 91916549 T AT91916549 T AT 91916549T AT E120753 T1 ATE120753 T1 AT E120753T1
- Authority
- AT
- Austria
- Prior art keywords
- acid derivatives
- bisphosphonic acid
- antiarthritic agents
- bisphosphonates
- agents
- Prior art date
Links
- 229940124346 antiarthritic agent Drugs 0.000 title abstract 3
- 239000003435 antirheumatic agent Substances 0.000 title abstract 3
- 239000002253 acid Substances 0.000 title 1
- 229940122361 Bisphosphonate Drugs 0.000 abstract 3
- -1 bicyclic bisphosphonates Chemical class 0.000 abstract 3
- 150000004663 bisphosphonates Chemical class 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000002599 prostaglandin synthase inhibitor Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4025—Esters of poly(thio)phosphonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3839—Polyphosphonic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/58—Pyridine rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/60—Quinoline or hydrogenated quinoline ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
- C07F9/6533—Six-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6536—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
- C07F9/6539—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6536—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
- C07F9/6539—Five-membered rings
- C07F9/6541—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/6552—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
- C07F9/65522—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring condensed with carbocyclic rings or carbocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
- C07F9/655345—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a five-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
- C07F9/655363—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a six-membered ring
- C07F9/655372—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a six-membered ring condensed with carbocyclic rings or carbocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
- C07F9/657163—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom
- C07F9/657181—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom the ring phosphorus atom and, at least, one ring oxygen atom being part of a (thio)phosphonic acid derivative
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Detergent Compositions (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US57027490A | 1990-08-21 | 1990-08-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE120753T1 true ATE120753T1 (de) | 1995-04-15 |
Family
ID=24278957
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT91916549T ATE120753T1 (de) | 1990-08-21 | 1991-08-09 | Bisphosphonsäurederivate als antiarthritische mittel. |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US5412141A (de) |
| EP (1) | EP0544812B1 (de) |
| JP (1) | JPH06500112A (de) |
| AT (1) | ATE120753T1 (de) |
| AU (1) | AU8495091A (de) |
| DE (1) | DE69108733T2 (de) |
| DK (1) | DK0544812T3 (de) |
| ES (1) | ES2072015T3 (de) |
| WO (1) | WO1992003451A1 (de) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0650360A1 (de) * | 1992-07-16 | 1995-05-03 | The Upjohn Company | Phosphonoderivate als entzündungshemmende und antiarthritische wirkstoffe |
| JPH08502287A (ja) * | 1992-10-09 | 1996-03-12 | ジ・アップジョン・カンパニー | 抗炎症剤としてのピリミジンビスホスホン酸エステルおよび（アルコキシメチルホスフィニル）アルキルホスホン酸 |
| JPH06135976A (ja) * | 1992-10-30 | 1994-05-17 | Toray Ind Inc | メタンジホスホン酸誘導体、その製造方法およびその医薬用途 |
| WO1994026279A1 (en) * | 1993-05-18 | 1994-11-24 | The Upjohn Company | Bisphosphonate esters for treating gastric disorders |
| EP0625522B1 (de) * | 1993-05-18 | 1998-08-19 | Takeda Chemical Industries, Ltd. | Benzopyran-Derivate und ihre Verwendung |
| US5795985A (en) * | 1996-03-05 | 1998-08-18 | Ciba Specialty Chemicals Corporation | Phenyl alkyl ketone substituted by cyclic amine and a process for the preparation thereof |
| GB9607945D0 (en) * | 1996-04-17 | 1996-06-19 | Univ Nottingham | Bisphosponates as Anti-inflammatory agents |
| US5994563A (en) * | 1997-04-01 | 1999-11-30 | Ortho Pharmaceutical Corporation | Arylmethylphosphonic acid derivatives useful in treating bone wasting diseases |
| US5990307A (en) * | 1997-08-01 | 1999-11-23 | American Home Products Corporation | Process for the preparation of [2-((8.9)-Dioxo-2,6-Diazabicyclo [5.2.0]-Non-1(7)-en-2yl) Ethyl]Phosphonic acid |
| HUP0102782A3 (en) | 1998-06-19 | 2002-12-28 | Smithkline Beecham Corp | Salycilanilide as inhibitors of transcription factor nf-kb |
| US6576436B1 (en) * | 1998-12-09 | 2003-06-10 | The Arizona Disease Control Research Commission | Anticancer agents based on prevention of protein prenylation |
| DK1175433T3 (da) | 1999-05-04 | 2005-09-19 | Strakan Int Ltd | Androgenglycosider og androgen aktivitet deraf |
| US6410520B2 (en) | 2000-02-01 | 2002-06-25 | The Procter & Gamble Company | Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1, 1-bisphosphonic acid sodium as the hemipentahydrate or monohydrate |
| US6562974B2 (en) | 2000-02-01 | 2003-05-13 | The Procter & Gamble Company | Process for making geminal bisphosphonates |
| US20060269602A1 (en) * | 2001-04-13 | 2006-11-30 | Dasch James R | Method of modifying the release profile of sustained release compositions |
| US6558702B2 (en) * | 2001-04-13 | 2003-05-06 | Alkermes Controlled Therapeutics, Inc. | Method of modifying the release profile of sustained release compositions |
| AU2003299029A1 (en) * | 2002-09-19 | 2004-04-08 | Ilex Oncology Research, Sarl | Substituted phosphonate compounds having bone anabolic activity |
| EP1644388A2 (de) * | 2003-06-27 | 2006-04-12 | ODANI, Akira | Bisphosphonatkomplexe |
| GT200400213A (es) * | 2003-10-22 | 2007-09-05 | Metodos para la preparacion del acido {2-[(8,9)-dioxo-2,6-diaza-biciclo[5.2.0]-non-1(7)-en-2-il]etil} fosfonico y esteres del mismo | |
| US20080021001A1 (en) | 2004-05-06 | 2008-01-24 | Donald Thompson | Methods For Treating Arthritic Conditions In Dogs |
| DE102005009457A1 (de) * | 2005-03-02 | 2006-09-07 | Bayer Cropscience Ag | Verfahren zum Herstellen von Alkylaniliden |
| US7863400B2 (en) * | 2006-08-01 | 2011-01-04 | University Of Massachusetts | Deoxybenzoin-based anti-flammable polyphosphonate and poly(arylate-phosphonate) copolymer compounds, compositions and related methods of use |
| ES2537216T3 (es) | 2009-09-01 | 2015-06-03 | Duke University | Composiciones de bisfosfonato y métodos para tratar la insuficiencia cardíaca |
| CN104010647A (zh) | 2011-11-16 | 2014-08-27 | 杜克大学 | 用于治疗和/或减轻心功能障碍的双膦酸盐组合物及方法 |
| CN103787910B (zh) * | 2014-03-05 | 2015-06-24 | 南通大学 | 一种有机中间体苯甲酰乙酰苯胺的制备方法 |
| WO2020080960A1 (en) * | 2018-10-19 | 2020-04-23 | Auckland Uniservices Limited | Compounds for treating diabetes and/or related conditions |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3683080A (en) * | 1970-08-28 | 1972-08-08 | Procter & Gamble | Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue |
| DE2637477A1 (de) * | 1976-08-20 | 1978-02-23 | Hoechst Ag | Dihydro-oxo-nicotinsaeuren und verfahren zu ihrer herstellung |
| NZ195564A (en) * | 1979-11-26 | 1983-09-30 | Sterling Drug Inc | 5-pyridinyl-2(1h)-pyridinones pharmaceutical compositions intermediate pyridine compounds |
| US4297360A (en) * | 1980-03-28 | 1981-10-27 | Sterling Drug Inc. | 5-(Pyridinyl)pyridine-2,3-diamines, preparation thereof and their cardiotonic use |
| US4325949A (en) * | 1980-02-15 | 1982-04-20 | American Cyanamid Company | Combinations of agents which give enhanced anti-inflammatory activity |
| FR2531088B1 (fr) * | 1982-07-29 | 1987-08-28 | Sanofi Sa | Produits anti-inflammatoires derives de l'acide methylenediphosphonique et leur procede de preparation |
| IT8367883A0 (it) * | 1982-08-23 | 1983-08-22 | Rorer Int Overseas | Composti cardiotonici del 2 piridone 5 biciclico eteroaril sostituito e relative composizioni farmaceutiche |
| PH27078A (en) * | 1984-12-21 | 1993-02-01 | Procter & Gamble | Pharmaceutical compositions containing geminal diphosphonates |
| DE3540150A1 (de) * | 1985-11-13 | 1987-05-14 | Boehringer Mannheim Gmbh | Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel |
| JPS63295595A (ja) * | 1986-10-27 | 1988-12-01 | Yamanouchi Pharmaceut Co Ltd | ３−置換−３−オキソープロピリデン−１，１−ジホスホン酸 |
| JPS63185993A (ja) * | 1987-01-27 | 1988-08-01 | Yamanouchi Pharmaceut Co Ltd | ２−置換−２−オキソ−エチレン−１，１−ジホスホン酸 |
| FR2611203B1 (fr) * | 1987-02-20 | 1989-06-09 | Sturtz Georges | Analogues gem-diphosphoniques d'amethopterine (methotrexate) et de derives deaza-n-10 amethopterine. leur preparation et les compositions pharmaceutiques qui les contiennent |
| DE3719513A1 (de) * | 1987-06-11 | 1988-12-22 | Boehringer Mannheim Gmbh | Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel |
| GB8809481D0 (en) * | 1988-04-21 | 1988-05-25 | Smith Kline French Lab | Chemical compounds |
| AU628158B2 (en) * | 1989-04-03 | 1992-09-10 | Upjohn Company, The | Geminal bisphosphonic acids and derivatives as anti-arthritic agents |
-
1991
- 1991-08-09 WO PCT/US1991/005554 patent/WO1992003451A1/en active IP Right Grant
- 1991-08-09 DE DE69108733T patent/DE69108733T2/de not_active Expired - Fee Related
- 1991-08-09 AU AU84950/91A patent/AU8495091A/en not_active Abandoned
- 1991-08-09 AT AT91916549T patent/ATE120753T1/de not_active IP Right Cessation
- 1991-08-09 JP JP3515080A patent/JPH06500112A/ja active Pending
- 1991-08-09 EP EP91916549A patent/EP0544812B1/de not_active Expired - Lifetime
- 1991-08-09 ES ES91916549T patent/ES2072015T3/es not_active Expired - Lifetime
- 1991-08-09 DK DK91916549.8T patent/DK0544812T3/da active
-
1993
- 1993-02-19 US US08/019,964 patent/US5412141A/en not_active Expired - Fee Related
-
1994
- 1994-11-28 US US08/345,508 patent/US5602115A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US5412141A (en) | 1995-05-02 |
| DE69108733T2 (de) | 1995-09-14 |
| ES2072015T3 (es) | 1995-07-01 |
| DK0544812T3 (da) | 1995-08-21 |
| US5602115A (en) | 1997-02-11 |
| JPH06500112A (ja) | 1994-01-06 |
| AU8495091A (en) | 1992-03-17 |
| EP0544812A1 (de) | 1993-06-09 |
| DE69108733D1 (de) | 1995-05-11 |
| WO1992003451A1 (en) | 1992-03-05 |
| EP0544812B1 (de) | 1995-04-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE120753T1 (de) | Bisphosphonsäurederivate als antiarthritische mittel. | |
| MX9302932A (es) | Nuevas 4-aza-5&-androstan-3-onas 7b-substituidas como inhibidores de la5&-reductasa. | |
| EP0097534A3 (en) | Phosphonyl hydroxyacyl amino acid derivatives as antihypertensives | |
| NO822793L (no) | Karbapenemderivater, fremgangsmaate til fremstilling av disse samt preparater som inneholder dem | |
| TR199700844T1 (xx) | Pirazolil-Benzoil T�revleri. | |
| FR2692265B1 (fr) | Composes biologiquement actifs de type phosphotriesters. | |
| EA199800106A1 (ru) | Соединения и содержащие их фармацевтические композиции | |
| BG101893A (en) | Nodulosporic acid derivatives | |
| MY101970A (en) | Zwitterionic bicyclic compounds and their salts, solvates, hydrates and esters. | |
| CA2026778A1 (en) | Dioxaphosphorinane compounds and polyolefin compositions stabilized therewith | |
| TNSN90042A1 (fr) | Procede de preparation des derives de la thieno-triazolo- diazepine | |
| ATE180470T1 (de) | Nipecotinsäurederivate als antithrombische verbindungen | |
| ZA883444B (de) | ||
| GR3031602T3 (en) | Novel 2-substituted indane-2-mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase. | |
| ATE207491T1 (de) | 1,2-dioxetan-derivate als wirkstoffe der chemolumineszenz | |
| AU626070B2 (en) | Anticoagulant peptide alcohols | |
| ES2062389T3 (es) | Acidos glutaramicos sustituidos y sus derivados. | |
| GR900100112A (el) | Μεθοδος παρασκευης ενωσεων πυριμιδο-πυριμιδινης αναστολεων της λιποξυγενασης. | |
| DE69002328D1 (de) | Geminale bisphosphonsaeuren und deren derivate als antiarthritische mittel. | |
| FI883207A0 (fi) | Foerfarande foer framstaellning av aminometylenfosfonoalkylfosfinater. | |
| ES2100274T3 (es) | Nuevos 2-sacarinilmetil y 4,5,6,7-tetrahidro-2-sacarinilmetil fosfatos, fosfonatos y fosfinatos utiles como inhibidores de enzimas proteoliticos y composiciones y metodos de empleo de los mismos. | |
| ATE171622T1 (de) | Antiallergische zusammensetzung enthaltend eine phosphorsäurediester-verbindung | |
| ES2187656T3 (es) | Derivados de acido fosfinico con actividad inhibidora de metalopeptidasa. | |
| DE69807857D1 (de) | Antitumorale bisphosphonate mit alkylierenden einheiten | |
| ES2030262T3 (es) | Lubricantes de esteres fosfatos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |